iHuman Statistics

Total Valuation

iHuman has a market cap or net worth of $109.85 million. The enterprise value is -$57.64 million.

Market Cap	109.85M
Enterprise Value	-57.64M

Important Dates

The next estimated earnings date is Thursday, June 20, 2024, before market open.

Earnings Date	Jun 20, 2024
Ex-Dividend Date	n/a

Share Statistics

iHuman has 51.65 million shares outstanding.

Shares Outstanding	51.65M
Owned by Insiders (%)	n/a
Owned by Institutions (%)	8.74%
Float	n/a

Valuation Ratios

The trailing PE ratio is 4.46 and the forward PE ratio is 58.14.

PE Ratio	4.46
Forward PE	58.14
PS Ratio	0.76
Forward PS	n/a
PB Ratio	0.83
P/FCF Ratio	4.79
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.00.

Current Ratio	2.82
Quick Ratio	2.60
Debt / Equity	0.00
Debt / EBITDA	0.02
Debt / FCF	0.02
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 20.20% and return on invested capital (ROIC) is 14.85%.

Return on Equity (ROE)	20.20%
Return on Assets (ROA)	13.10%
Return on Capital (ROIC)	14.85%
Revenue Per Employee	$183,400
Profits Per Employee	$32,587
Employee Count	783
Asset Turnover	0.74
Inventory Turnover	16.66

Taxes

In the past 12 months, iHuman has paid $3.00 million in taxes.

Income Tax	3.00M
Effective Tax Rate	10.52%

Stock Price Statistics

The stock price has decreased by -45.33% in the last 52 weeks. The beta is 0.35, so iHuman's price volatility has been lower than the market average.

Beta (1Y)	0.35
52-Week Price Change	-45.33%
50-Day Moving Average	1.81
200-Day Moving Average	2.51
Relative Strength Index (RSI)	70.94
Average Volume (30 Days)	28,537

Short Selling Information

Short Interest	755
Short Previous Month	1,241
Short % of Shares Out	0.00%
Short % of Float	n/a
Short Ratio (days to cover)	0.03

Income Statement

In the last 12 months, iHuman had revenue of $143.60 million and earned $25.52 million in profits. Earnings per share was $0.46.

Revenue	143.60M
Gross Profit	99.85M
Operating Income	22.13M
Pretax Income	28.04M
Net Income	25.52M
EBITDA	29.66M
EBIT	28.04M
Earnings Per Share (EPS)	$0.46

Full Income Statement

Balance Sheet

The company has $168.03 million in cash and $534,360 in debt, giving a net cash position of $167.49 million or $3.24 per share.

Cash & Cash Equivalents	168.03M
Total Debt	534,360
Net Cash	167.49M
Net Cash Per Share	$3.24
Equity / Book Value	132.59M
Book Value Per Share	2.57
Working Capital	123.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $23.83 million and capital expenditures -$901,074, giving a free cash flow of $22.93 million.

Operating Cash Flow	23.83M
Capital Expenditures	-901,074
Free Cash Flow	22.93M
FCF Per Share	$0.43

Full Cash Flow Statement

Margins

Gross margin is 69.53%, with operating and profit margins of 15.41% and 17.77%.

Gross Margin	69.53%
Operating Margin	15.41%
Pretax Margin	19.53%
Profit Margin	17.77%
EBITDA Margin	20.66%
EBIT Margin	19.53%
FCF Margin	15.97%

Dividends & Yields

iHuman does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.32%
Shareholder Yield	-1.32%
Earnings Yield	23.23%
FCF Yield	20.87%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

iHuman has an Altman Z-Score of 2.74 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.74
Piotroski F-Score	7